North America Cell Therapy Bioprocessing Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Bioreactor, Lyophilization, Electrospinning, Control flow Centrifugation, Ultrasonic Lysis, Genome Editing Technology, Cell Immortalization Technology, and Viral Vector Technology); Cell Type (Stem Cell, Immune Cell, Human Embryonic Stem Cell, Pluripotent Stem Cell, and Hematopoietic Stem Cells), Indication (Cardiovascular Disease (CVD), Oncology, Wound Healing, Orthopaedic, and Others); End User (Hospitals and Clinics, Diagnostic Centres, Regenerative Medicine Centres, and Academic and Research Institute)

No. of Pages: 168    |    Report Code: TIPRE00024510    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Cell Therapy Bioprocessing Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Cell Therapy Bioprocessing Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Cell Therapy Bioprocessing Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Cell therapy approvals growing
  • 5.1.3 Chronic diseases and cancer driving demand
  • 5.1.4 Gene-editing and stem cell technologies advancing
  • 5.1.5
5.2 Market Opportunities
  • 5.2.1
  • 5.2.2 Growing adoption of automated bioprocessing systems for scalable and efficient cell production.
  • 5.2.3 Expansion into emerging markets with improving healthcare infrastructure and biomanufacturing capabilities.
  • 5.2.4 Rising collaborations between biotech companies and research institutions for novel therapy development.
5.3 Future Trends
  • 5.3.1
  • 5.3.2 Development of closed-system bioprocessing for enhanced safety and contamination control.
  • 5.3.3 Growth in personalized cell therapies requiring flexible and small-scale bioprocessing solutions.
  • 5.3.4 Increasing integration of AI and machine learning for optimized cell therapy production and quality control.
5.4 Impact of Drivers and Restraints

6. North America Cell Therapy Bioprocessing Market Regional Analysis

6.1 North America Cell Therapy Bioprocessing Market Overview
6.2 North America Cell Therapy Bioprocessing Market Revenue 2019-2028 (US$ Million)
6.3 North America Cell Therapy Bioprocessing Market Forecast Analysis

7. North America Cell Therapy Bioprocessing Market Analysis – by Technology

7.1 Bioreactor
  • 7.1.1 Overview
  • 7.1.2 Bioreactor: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Lyophilization
  • 7.2.1 Overview
  • 7.2.2 Lyophilization: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Electrospinning
  • 7.3.1 Overview
  • 7.3.2 Electrospinning: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Control flow Centrifugation
  • 7.4.1 Overview
  • 7.4.2 Control flow Centrifugation: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Ultrasonic Lysis
  • 7.5.1 Overview
  • 7.5.2 Ultrasonic Lysis: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Genome Editing Technology
  • 7.6.1 Overview
  • 7.6.2 Genome Editing Technology: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Cell Immortalization Technology
  • 7.7.1 Overview
  • 7.7.2 Cell Immortalization Technology: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Viral Vector Technology
  • 7.8.1 Overview
  • 7.8.2 Viral Vector Technology: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Cell Therapy Bioprocessing Market Analysis – by Cell Type

8.1 Stem Cell
  • 8.1.1 Overview
  • 8.1.2 Stem Cell: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Immune Cell
  • 8.2.1 Overview
  • 8.2.2 Immune Cell: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Human Embryonic Stem Cell
  • 8.3.1 Overview
  • 8.3.2 Human Embryonic Stem Cell: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Pluripotent Stem Cell
  • 8.4.1 Overview
  • 8.4.2 Pluripotent Stem Cell: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Hematopoietic Stem Cells
  • 8.5.1 Overview
  • 8.5.2 Hematopoietic Stem Cells: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Cell Therapy Bioprocessing Market Analysis – by Indication

9.1 Cardiovascular Disease
  • 9.1.1 Overview
  • 9.1.2 Hematopoietic Stem Cells: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Oncology
  • 9.2.1 Overview
  • 9.2.2 Hematopoietic Stem Cells: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Wound Healing
  • 9.3.1 Overview
  • 9.3.2 Hematopoietic Stem Cells: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Orthopaedic
  • 9.4.1 Overview
  • 9.4.2 Hematopoietic Stem Cells: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Cell Therapy Bioprocessing Market – North America Analysis

10.1 North America
  • 10.1.1 North America Cell Therapy Bioprocessing Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Cell Therapy Bioprocessing Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Cell Therapy Bioprocessing Market Breakdown, by Technology
    • 10.1.1.1.2 US: North America Cell Therapy Bioprocessing Market Breakdown, by Cell Type
    • 10.1.1.1.3 US: North America Cell Therapy Bioprocessing Market Breakdown, by Indication
  • 10.1.1.2 Canada: North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Cell Therapy Bioprocessing Market Breakdown, by Technology
    • 10.1.1.2.2 Canada: North America Cell Therapy Bioprocessing Market Breakdown, by Cell Type
    • 10.1.1.2.3 Canada: North America Cell Therapy Bioprocessing Market Breakdown, by Indication
  • 10.1.1.3 Mexico : North America Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Cell Therapy Bioprocessing Market Breakdown, by Technology
    • 10.1.1.3.2 Mexico : North America Cell Therapy Bioprocessing Market Breakdown, by Cell Type
    • 10.1.1.3.3 Mexico : North America Cell Therapy Bioprocessing Market Breakdown, by Indication

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Cell Therapy Bioprocessing Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Fresenius Kabi Ag.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Asahi Kasei Corporation
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Sartorius Ag
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Merck Kgaa
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Corning Incorporated
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Cytiva (Ge Healthcare)
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Lonza
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Repligen
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Catalent Inc
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Cell Therapy Bioprocessing Market

  1. Fresenius Kabi Ag.
  2. Asahi Kasei Corporation
  3. Sartorius Ag
  4. Merck Kgaa
  5. Thermo Fisher Scientific Inc.
  6. Corning Incorporated
  7. Cytiva (Ge Healthcare)
  8. Lonza
  9. Repligen
  10. Catalent Inc
north-america-cell-therapy-bioprocessing-market